CN1685976A - Liposoluble composite vitamin microelement and manufacturing method - Google Patents
Liposoluble composite vitamin microelement and manufacturing method Download PDFInfo
- Publication number
- CN1685976A CN1685976A CNA2005100208551A CN200510020855A CN1685976A CN 1685976 A CN1685976 A CN 1685976A CN A2005100208551 A CNA2005100208551 A CN A2005100208551A CN 200510020855 A CN200510020855 A CN 200510020855A CN 1685976 A CN1685976 A CN 1685976A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- trace element
- selenium
- food
- square
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002131 composite material Substances 0.000 title claims abstract description 12
- 229940088594 vitamin Drugs 0.000 title claims description 13
- 229930003231 vitamin Natural products 0.000 title claims description 13
- 235000013343 vitamin Nutrition 0.000 title claims description 13
- 239000011782 vitamin Substances 0.000 title claims description 13
- 150000003722 vitamin derivatives Chemical class 0.000 title claims description 13
- 238000004519 manufacturing process Methods 0.000 title claims description 9
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 14
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 12
- 239000011573 trace mineral Substances 0.000 claims abstract description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 20
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 15
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 15
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 15
- 235000019155 vitamin A Nutrition 0.000 claims description 15
- 239000011719 vitamin A Substances 0.000 claims description 15
- 229940045997 vitamin a Drugs 0.000 claims description 15
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 13
- 235000013305 food Nutrition 0.000 claims description 13
- 239000011701 zinc Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 229930003316 Vitamin D Natural products 0.000 claims description 11
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 11
- 239000011669 selenium Substances 0.000 claims description 11
- 235000019166 vitamin D Nutrition 0.000 claims description 11
- 239000011710 vitamin D Substances 0.000 claims description 11
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 11
- 229940046008 vitamin d Drugs 0.000 claims description 11
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 10
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 10
- 241001330002 Bambuseae Species 0.000 claims description 10
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 10
- 229930003427 Vitamin E Natural products 0.000 claims description 10
- 239000011425 bamboo Substances 0.000 claims description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 10
- 235000019165 vitamin E Nutrition 0.000 claims description 10
- 229940046009 vitamin E Drugs 0.000 claims description 10
- 239000011709 vitamin E Substances 0.000 claims description 10
- 235000013619 trace mineral Nutrition 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 235000013373 food additive Nutrition 0.000 claims description 5
- 239000002778 food additive Substances 0.000 claims description 5
- 229910000831 Steel Inorganic materials 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 239000012047 saturated solution Substances 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 239000010959 steel Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000008215 water for injection Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 2
- 230000002354 daily effect Effects 0.000 claims 3
- 230000003203 everyday effect Effects 0.000 claims 1
- 208000004930 Fatty Liver Diseases 0.000 abstract description 5
- 206010019708 Hepatic steatosis Diseases 0.000 abstract description 5
- 208000010706 fatty liver disease Diseases 0.000 abstract description 5
- 231100000240 steatosis hepatitis Toxicity 0.000 abstract description 5
- 208000008589 Obesity Diseases 0.000 abstract description 2
- 239000008157 edible vegetable oil Substances 0.000 abstract description 2
- 235000020824 obesity Nutrition 0.000 abstract description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 150000001746 carotenes Chemical class 0.000 abstract 1
- 235000005473 carotenes Nutrition 0.000 abstract 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 5
- 235000013734 beta-carotene Nutrition 0.000 description 4
- 239000011648 beta-carotene Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 208000010011 Vitamin A Deficiency Diseases 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000007952 growth promoter Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 208000005368 osteomalacia Diseases 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 102000003846 Carbonic anhydrases Human genes 0.000 description 1
- 108090000209 Carbonic anhydrases Proteins 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 108020005199 Dehydrogenases Proteins 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010047631 Vitamin E deficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000570 acute poisoning Toxicity 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- -1 lipid peroxide Chemical class 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 201000001514 prostate carcinoma Diseases 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 208000029584 urinary system neoplasm Diseases 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A liposoluble composite vitamine-trace element product for preventing obesity and fatty liver and losing weight is prepared from VA, VD, VE, carotene, Se and Zn. It can be used as the additive of ordinary edible oil.
Description
Technical field: the invention belongs to field of food.
Background technology: human body depot fat 70% all is an oleic acid, its metabolism need consume a large amount of fat-soluble As and provitamin A Hu square-bottomed bamboo basket Bu Su, vitamin D, vitamin E and trace element-selenium, zinc etc., control is fat, fatty liver and fat-reducing etc. need to consume more these materials, otherwise effect extreme difference not only, and can have a strong impact on physical and mental health, old friend's body lacks fatty homenergic and structural material metabolism and health is very important and easy again fat-soluble A that lacks and provitamin A Hu square-bottomed bamboo basket Bu Su, D, E and trace element-selenium, zinc etc. are to solving above-mentioned control obesity, serial global problem such as fatty liver and fat-reducing all has good action.
Summary of the invention:
Total be exactly the present invention is for addressing this problem, providing a kind of liposoluble composite vitamin micro element and manufacture method for one inventive concept.Be that beneficial effect is described below now with scientific and technological principle of the present invention and function.
Vitamin A only is present in the animal food, and the provitamin A that does not have a physiologically active recklessly square-bottomed bamboo basket is foretold usually from plant, can change the vitamin A that physiologically active is arranged in human body.Vitamin A can promote growth promoter, vision enhancing protection eyes, to infant and juvenile healthy growing particular importance, prevent and treat pigmentation and sebum line angleization, make skin can obtain the fat protection and avoid drying itch, to the health care for the middle and old aged particular importance.In addition, vitamin A deficiency is easily impelled the chemical carcinogen induced tumor, as the oral mucosa tumor, cutaneous papilloma, carcinoma of submaxilary gland, hepatocarcinoma, and thereby increase hepatomicrosome oxidase active increases carcinogenic activity material in the body, vitamin A can prevent epithelial conversion and can make that cancerous tumor cell recovers normal in a word, repair epithelium and comprise digestive tract, respiratory tract, urethra and reproductive system cells injury promote energy and energy matter to synthetic protein so can prevent various tumors, mucopolysaccharide, structure such as glycoprotein and immune material transform and prevent and treat fat homenergic metabolism disorder disease, improve health conditions.But within a short period of time can not be with heavy dose of vitamin A otherwise easy acute poisoning and cause fetal anomaly, and the provitamin A avirulence, can be converted into vitamin A according to actual requirement in the body, share then with vitamin A and can take into account mutually, bring out the best in each other.Vitamin D is the same with vitamin A main from animal food such as liver, milk, egg yolk, and is in close relations with calcium, phosphorus metabolism, lacks to cause children rachitis, adult osteomalacia, particularly anemia of pregnant woman and wet nurse Geng Yi that osteomalacia takes place.In addition, vitamin D and vitamin A are that tooth generates and the necessary nutrient of growing, can cause that as vitamin A deficiency the enamel calcification is incomplete, adult's bone and tooth calcium all are in dynamic equilibrium but not are unalterable, thus be deficient in vitamin D and vitamin A healthhazard and not second to children and youth even because of adult's repair function to be lower than the children and youth hazardness bigger.Vitamin E has anti-oxidation function and prevents that with collaborative the finishing of selenium polyunsaturated fatty acid is oxidized to the function of lipid peroxide, with growth promoter, delay senility, promotion blood capillary proliferation microcirculation improvement, prevent arteriosclerosis and other cardiovascular disease, suppress thrombosis, anticancer etc. substantial connection arranged all.Vitamin E deficiency and during with protein deficient can cause acute liver cirrhosis, generation giant cell hemolytic anemia.Selenium is powerful antioxidant, both sides' oxidation resistance and effect will significantly be improved during especially with the vitamin E use in conjunction, can prevent carcinogen to combine by antioxidation with host cell, and can suppress the vigor of lysosomal enzyme system in the cell, strengthen the Detoxication of body and prophylaxis of cancer, the generation of its intake and breast carcinoma, ovarian cancer, colon cancer, rectal cancer, carcinoma of prostate, leukemia, gastroenteric tumor, urinary tract tumor etc. all is negative correlation, especially the esophageal carcinoma.The activity of zinc and 300 plurality of enzymes such as carbonic anhydrase, some kinds of dehydrogenases is relevant, zinc deficiency appetite and immunity degradation, growth retardation, the pancreas zinc content of diabetics is half of normal person only, leukaemic's leucocyte zinc content only normal contents 10%, its leukocytic zinc content also had raising even can arrive normal level when symptom made moderate progress after treating.In addition, product of the present invention also has and has no side effect, no hormone, no age, sex, season and do not have scope of application restriction, the simple cost of production technology is low makes serial significant advantage such as most people can both afford to consume, and has accomplished that really modern high technology is the invention aim that most people work for Gospel.
The specific embodiment:
Liposoluble composite vitamin micro element is made up of fat-soluble A, Hu square-bottomed bamboo basket Bu Su, vitamin D, vitamin E, trace element-selenium and trace element zinc, various raw materials and consumption are vitamin A 3-6 part, β-Hu square-bottomed bamboo basket Bu Su 0-6 part, vitamin D 0.05-0.15 part, vitamin E 40-180 part, trace element-selenium 0.05-0.2 part, trace element zinc 0-60 part, or by the GB-2760 food additive use sanitary standard and GB14880 food enrichment use other kind of sanitary standard approval select for use or share, consumption vitamin and trace element conversion according to target.Directly edible as food additive or replacement edible oil, consumption sees that embodiment is described.
Manufacture method is:
In sterilizing room, get the above vitamin A 3-6 of food stage part respectively, β-Hu square-bottomed bamboo basket Bu Su 0-6 part, vitamin D 0.05-0.15 part, vitamin E 40-180 part, join in the rustless steel container of belt stirrer, 60-120 rev/min rotating speed at the uniform velocity stirred 2-3 minute, to use sterilized water such as water for injection in advance again, distilled water, whole saturated solutions that dissolved in purified water trace element-selenium 0.05-0.2 part and trace element zinc 0-60 part make synchronously at the uniform velocity, even spraying finishes, the rotating speed that continues again with 120-200 rev/min at the uniform velocity stirs 20-30 minute abundant mixing, heat in this process and keep 105-110 ℃ to remove moisture, liposoluble composite vitamin micro element.
Embodiment: in sterilizing room, get the above vitamin A 3-6 of food stage part respectively, β-Hu square-bottomed bamboo basket Bu Su 3-6 part, vitamin D 0.05-0.15 part, vitamin E 40-180 part, join in the rustless steel container of belt stirrer, 60-120 rev/min rotating speed at the uniform velocity stirred 2-3 minute, to use sterilized water such as water for injection in advance again, distilled water, whole saturated solutions that dissolved in purified water trace element-selenium 0.05-0.2 part and trace element zinc 20-60 part make synchronously at the uniform velocity, even spraying finishes, the rotating speed that continues again with 120-200 rev/min at the uniform velocity stirs 20-30 minute abundant mixing, heat in this process and keep 105-110 ℃ to remove moisture, liposoluble composite vitamin micro element.Liposoluble composite vitamin micro element of the present invention can be made for food additive and use, consumption is not limit, is got final product by the use of ordinary production requirement, the content of suggestion in the directly edible daily intaking amount food of terminal is: the daily intaking amount of crowd below 14 years old 5-10 milligram, crowd's daily intaking amount 10-15 milligram more than 14 years old, be divided into edible being advisable 2-3 time, maximum daily intaking amount is no more than 30 milligrams; Also direct-edible, for instant, can dilute filling with food or medicine filler and binding agent such as starch, dextrin etc. by above-mentioned suitable dosage, molding is as making shapes such as tablet, granule, or not molding all can as shapes such as powder, it is more convenient also to can be made into the use of glue oil ball, looks different application targets and production series of products easy to use.
In view of guidelines for examination is only required the open experimental effect data information of medicine etc., food is not had this requirement and national legislation forbid food propaganda curative effect, and description belongs to public publication, overt propaganda food experimental effect data informations etc. are inconsistent with regulation with above-mentioned law, so only from general representational fatty liver zoopery of scientific and technological angle brief introduction tool and result: (liver fat content is normal below 5% to causing severe through raising earlier, slight 5-10%, moderate 10-25%, severe is more than 25%, seriously can reach 50%) fatty liver goes the curative test group again and feeds embodiment of the invention product 5-10 mg/day with feedstuff, matched group does not have, observe about first quarter moon, experimental group liver fat content is all about 7-9%, belong to slight fat content index; Promptly take an evident turn for the better,, illustrate that the rehabilitation degree has than big-difference about 15-20% though matched group liver fat content still has clear improvement but still belongs to moderate.Can return to one's perfect health and required time difference though fail clearly to contrast, suffice to show that each product effect of the present invention is all remarkable because of the feeding time weak point.
Claims (3)
1, a kind of liposoluble composite vitamin micro element, it is characterized in that by fat-soluble A, Hu square-bottomed bamboo basket Bu Su, vitamin D, vitamin E, trace element-selenium and trace element zinc are formed, various raw materials and consumption are vitamin A 3-6 part, β-Hu square-bottomed bamboo basket Bu Su 0-6 part, vitamin D 0.05-0.15 part, vitamin E 40-180 part, trace element-selenium 0.05-0.2 part, trace element zinc 0-60 part, or use sanitary standard and GB14880 food enrichment to use other kind choosing of sanitary standard approval or share by the GB-2760 food additive, consumption vitamin and microelement conversion according to target.
2, the manufacture method of liposoluble composite vitamin micro element according to claim 1, it is characterized in that: in sterilizing room, get the above vitamin A 3-6 of food stage part respectively, β-Hu square-bottomed bamboo basket Bu Su 0-6 part, vitamin D 0.05-0.15 part, vitamin E 40-180 part, join in the rustless steel container of belt stirrer, 60-120 rev/min rotating speed at the uniform velocity stirred 2-3 minute, to use sterilized water such as water for injection in advance again, distilled water, whole saturated solutions that dissolved in purified water trace element-selenium 0.05-0.2 part and trace element zinc 0-60 part make synchronously at the uniform velocity, even spraying finishes, the rotating speed that continues again with 120-200 rev/min at the uniform velocity stirs 20-30 minute abundant mixing, heat in this process and keep 105-110 ℃ to remove moisture, liposoluble composite vitamin micro element.
3, the purposes of liposoluble composite vitamin micro element product according to claim 2 is characterized in that: as food additive, consumption is not limit, is used by the ordinary production requirement; Directly edible, the daily intaking amount of crowd below 14 years old 5-10 milligram, crowd's daily intaking amount 10-15 milligram, every day divide and eat 30 milligrams of maximum daily intaking amounts 2-3 time more than 14 years old.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2005100208551A CN1685976A (en) | 2005-05-08 | 2005-05-08 | Liposoluble composite vitamin microelement and manufacturing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2005100208551A CN1685976A (en) | 2005-05-08 | 2005-05-08 | Liposoluble composite vitamin microelement and manufacturing method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1685976A true CN1685976A (en) | 2005-10-26 |
Family
ID=35304018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2005100208551A Pending CN1685976A (en) | 2005-05-08 | 2005-05-08 | Liposoluble composite vitamin microelement and manufacturing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1685976A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012087487A1 (en) * | 2010-12-20 | 2012-06-28 | Hill's Pet Nutrition, Inc. | Pet food compositions for inducing a satiety response |
| CN112438393A (en) * | 2019-08-28 | 2021-03-05 | 深圳奥萨制药有限公司 | Composition with auxiliary tumor prevention effect |
-
2005
- 2005-05-08 CN CNA2005100208551A patent/CN1685976A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012087487A1 (en) * | 2010-12-20 | 2012-06-28 | Hill's Pet Nutrition, Inc. | Pet food compositions for inducing a satiety response |
| RU2543539C2 (en) * | 2010-12-20 | 2015-03-10 | Хилл'С Пет Ньютришн, Инк. | Food composition for pets, causing sense of fullness |
| US9861116B2 (en) | 2010-12-20 | 2018-01-09 | Hill's Pet Nutrition, Inc. | Pet food compositions for inducing a satiety response |
| CN112438393A (en) * | 2019-08-28 | 2021-03-05 | 深圳奥萨制药有限公司 | Composition with auxiliary tumor prevention effect |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103598334A (en) | Fruit and vegetable yogurt drink and preparation method thereof | |
| WO2011160420A1 (en) | Green milk | |
| KR101539382B1 (en) | Food composition for improvement of bowel function and relief of constipation | |
| CN102144748A (en) | Five-color flour food with functions of excreting toxins, protecting liver and maintaining beauty | |
| CN110584101A (en) | Pont bird's nest, preparation method and beverage | |
| CN113615783A (en) | Yak collagen peptide sports drink | |
| CN107232471A (en) | A kind of nutrient solid beverage | |
| CN1275534C (en) | Corn peptide beverage and its processing method | |
| CN104382129A (en) | Beverage prepared from sweet corn and black tea fungus | |
| CN101077144A (en) | Fruity Noodles | |
| CN101347195B (en) | Compound coarse cereals nutrition paste and method of preparing the same | |
| CN101455345A (en) | Folium cortex eucommiae, gastrodia tuber nutrient effervescence tablet and manufacture method thereof | |
| CN101103816B (en) | Sea-buckthorn nutrient food additive and flour composition containing thereof | |
| CN1685976A (en) | Liposoluble composite vitamin microelement and manufacturing method | |
| CN104509915A (en) | Preparation method of tomato vinegar | |
| CN103271353B (en) | Liver protecting and health care composition and preparation method thereof | |
| CN101700068B (en) | A kind of preparation method of high-calcium beverage that can promote children's bone growth | |
| CN1685974A (en) | Liposoluble composite vitamin microelement and nutritive edible oil product and manufacturing method | |
| CN1685902A (en) | Liposoluble composite vitamin micro element and essential fatty acid and nutritive type edible oil and manufacturing method | |
| CN102511882A (en) | Red jujube thick syrup beneficial for improving growth and development | |
| CN102370134A (en) | Tomato and beef noodle and preparation method thereof | |
| CN102150837A (en) | Formula of ferroheme peptide chewable tablets and making method of ferroheme peptide chewable tablets | |
| CN1056626A (en) | Duoweikang nourishing agent | |
| CN101507488A (en) | Composite reinforced nutritious chicken essence | |
| RU2363268C1 (en) | Dietary supplement |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |